Navigation Links
Einstein researchers lead panels at NIH Aging and Chronic Disease Symposium on Geroscience

October 29, 2013 (BRONX, NY) The National Institutes of Health (NIH) has chosen two leading aging researchers at Albert Einstein College of Medicine of Yeshiva University to chair panels at the first symposium on "geroscience"the study of how aging influences the onset of chronic diseases.

Aging is a major risk factor for major chronic diseases including cancer, cardiovascular disease and diabetes. Understanding the biological processes that underlie aging could lead to new ways of treating or even preventing chronic disease.

The NIH symposium is the first to take an integrated approach to studying diseases associated with aging. Each of its seven panels will focus on a different broad area of research: inflammation, adaption to stress, epigenetics, metabolism, macromolecular damage, proteostasis and adult stem cells and regeneration.

Jeffrey Pessin, Ph.D., director of Einstein's Diabetes Research Center, and Christopher Newgard, Ph.D., of Duke University School of Medicine, will co-chair the panel on metabolism and how making it more efficient could help fight age-related diseases processes. Dr. Pessin holds the Judy R. and Alfred A. Rosenberg Professorial Chair in Diabetes Research and is professor of medicine and of molecular pharmacology at Einstein.

Ana Maria Cuervo, M.D., Ph.D., co-director of Einstein's Institute for Aging Research, will co-chair the panel on proteostasis with Richard Morimoto, Ph.D., of Northwestern University. Proteostasis involves preserving cell function by preventing cell proteins from either degrading or accumulating as we age. Dr. Cuervo is professor of developmental and molecular biology, of anatomy and structural biology, and of medicine and holds the Robert and Renee Belfer Chair for the Study of Neurodegenerative Diseases.

Two other Einstein researchers will make presentations at the summit:

Featuring National Institutes of Health (NIH) director Francis Collins, the "Advances in Geroscience: Impact on Healthspan and Chronic Disease" scientific summit was organized by the trans-NIH Geroscience Interest Group (GSIG) with support from the Alliance for Aging Research and The Gerontological Society of America. Among the largest trans-NIH interest groups, the GSIG focuses on the relationships between aging and age-related disease and disability. More information and the Summit's agenda are available here.


Contact: Deirdre Branley
Albert Einstein College of Medicine

Related medicine news :

1. How does aging affect cancer? Einstein awarded $2.8m grant to answer NCI provocative question
2. Albert Einstein Cancer Center begins 40th year of continuous NIH support with $17 million grant
3. Feinstein Institute Researcher Organizes LI Alzheimer’s Consortium
4. Feinstein Institute to Receive $330,000 Grant to Support Research of Childhood Cancer
5. North Shore-LIJ Health System's Feinstein Institute to Receive $250,000 Grant from Lymphoma Research Foundation Grant to support research of Chronic Lymphocytic Leukemia
6. Summer Benefit Concert Raised More Than $1.5 Million for Feinstein Institute
7. Long Island Bike Challenge Rides to Raise Money for North Shore-LIJ's Feinstein Institute of Medical Research
8. Feinstein Institute, Hofstra North Shore-LIJ School of Medicine at 36th Annual Conference on Shock
9. North Shore-LIJ's Feinstein Institute Hosts Academic Commencement and Convocation
10. North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week
11. Feinstein Institute Researcher provides insight into osteoarthritis
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... The print ... USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation ... is distributed nationally, through a vast social media strategy and across a network ...
(Date:11/27/2015)... ... November 27, 2015 , ... Consistent ... sharing, the 2016 Building Better Radiology Marketing Programs meeting will showcase ... Sunday, March 6, 2016, at Caesars Palace in Las Vegas with a pre-conference ...
(Date:11/27/2015)... ... November 27, 2015 , ... The moment you stop improving ... only fulfilling the needs of advisers and clients but going above and beyond ... top-tier customer service. However, there's always room for improvement, which is why the ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... the largest, most successful and prominent nonprofit healthcare organizations in the country. They ... involvement with various organizations, and helped advance the healthcare industry as a whole ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft ... announces the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite ... LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... UTRECHT , Niederlande, November 27, 2015 /PRNewswire/ ... mit fotodynamischer Bremachlorin-Therapie bei fortgeschrittenem Krebs.   ... fotodynamischer Bremachlorin-Therapie bei fortgeschrittenem Krebs.   --> ... fotodynamischer Bremachlorin-Therapie bei fortgeschrittenem Krebs.   ... berichtet. --> Clinical Cancer Research ...
(Date:11/26/2015)... Países Bajos, November 26, 2015 ... fotodinámica de Bremachlorin para el cáncer avanzado.   ... con la terapia fotodinámica de Bremachlorin para el cáncer ... enfoque combina la inmunoterapia con la terapia fotodinámica de ... Clinical Cancer Research . --> Clinical Cancer ...
(Date:11/26/2015)... -- Research and Markets ( ) has announced the ... to 2019 - Rise in Cardiac Disorders and Growing Awareness ... their offering. Boston scientific ... scientific and others. --> The market is ... Boston scientific and others. ...
Breaking Medicine Technology: